| Literature DB >> 7142476 |
L S McCormack, M L Elgart, M L Turner.
Abstract
Benoxaprofen (Opren) is a nonsteroidal anti-inflammatory agent used in the treatment of arthritis. Photosensitivity, including onycholysis, has been reported in the rheumatologic literature. This drug has recently been approved for use in the United States under the name of Oraflex. In order to alert the dermatology community, we report a case of photo-onycholysis which developed in a patient being treated with benoxaprofen and review the data on this drug and its side effects.Entities:
Mesh：
Substances：
Year: 1982 PMID： 7142476 DOI： 10.1016/s0190-9622(82)70151-3
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527